Bilal Muhsin Sells 10,000 Shares of Masimo Co. (NASDAQ:MASI) Stock

Masimo Co. (NASDAQ:MASI) COO Bilal Muhsin sold 10,000 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $163.28, for a total transaction of $1,632,800.00. Following the transaction, the chief operating officer now directly owns 24,172 shares in the company, valued at approximately $3,946,804.16. The trade was a 29.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Bilal Muhsin also recently made the following trade(s):

• On Monday, March 10th, Bilal Muhsin sold 30,000 shares of Masimo stock. The shares were sold at an average price of $167.49, for a total transaction of $5,024,700.00.

Masimo Stock Up 0.8%

Shares of NASDAQ:MASI opened at $154.39 on Friday. The company has a market capitalization of $8.37 billion, a PE ratio of 106.48 and a beta of 1.23. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Masimo Co. has a twelve month low of $101.61 and a twelve month high of $194.88. The firm has a 50 day simple moving average of $160.28 and a 200-day simple moving average of $167.06.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.12. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The business had revenue of $372.00 million during the quarter, compared to the consensus estimate of $367.79 million. During the same quarter in the previous year, the firm earned $0.77 EPS. The company’s revenue was down 24.5% compared to the same quarter last year. On average, equities analysts predict that Masimo Co. will post 4.1 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently commented on MASI. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Thursday, April 10th. Raymond James dropped their price target on shares of Masimo from $204.00 to $185.00 and set an “outperform” rating for the company in a research report on Wednesday, May 7th. Piper Sandler reiterated an “overweight” rating and set a $200.00 price target (down from $215.00) on shares of Masimo in a research report on Wednesday, May 7th. BTIG Research set a $193.00 price objective on shares of Masimo and gave the company a “buy” rating in a research note on Wednesday, May 7th. Finally, Wells Fargo & Company lowered their price objective on shares of Masimo from $205.00 to $190.00 and set an “overweight” rating for the company in a research note on Wednesday, May 7th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $191.60.

Institutional Trading of Masimo

Several institutional investors and hedge funds have recently bought and sold shares of MASI. Smartleaf Asset Management LLC increased its stake in Masimo by 31.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 250 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 60 shares during the period. EverSource Wealth Advisors LLC grew its stake in Masimo by 40.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 64 shares during the last quarter. Blue Trust Inc. grew its stake in Masimo by 56.3% in the 4th quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 71 shares during the last quarter. Xponance Inc. grew its stake in Masimo by 1.1% in the 1st quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider’s stock valued at $1,183,000 after acquiring an additional 76 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in Masimo by 0.8% in the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,815 shares of the medical equipment provider’s stock valued at $1,622,000 after acquiring an additional 82 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.